Print this page
Monday, 11 May 2015 10:10

Cost-Effectiveness Analysis of Routine Surveillance Imaging of Patients With Diffuse Large B-Cell Lymphoma in First Remission

Written by 
Rate this item
(0 votes)

Conclusion of study "cost-effectiveness analysis suggests surveillance imaging of asymptomatic DLBCL patients in remission offers little clinical benefit at substantial economic costs."

Read 214881 times Last modified on Wednesday, 25 January 2017 14:52